In recent trading session, Applied Dna Sciences Inc (NASDAQ:APDN) saw 0.64 million shares changing hands at last check today with its beta currently measuring 0.38. Company’s recent per share price level of $0.16 trading at $0.0 or -2.87% at last check today assigns it a market valuation of $8.77M. That most recent trading price of APDN’s stock is at a discount of -8900.0% from its 52-week high price of $14.40 and is indicating a premium of 25.0% from its 52-week low price of $0.12.
For Applied Dna Sciences Inc (APDN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.33 in the current quarter.
Applied Dna Sciences Inc (NASDAQ:APDN) trade information
Upright in the red during last session for losing -2.87%, in the last five days APDN remained trading in the red while hitting it’s week-highest on Thursday, 02/13/25 when the stock touched $0.16 price level, adding 15.61% to its value on the day. Applied Dna Sciences Inc’s shares saw a change of -22.06% in year-to-date performance and have moved -16.23% in past 5-day. Applied Dna Sciences Inc (NASDAQ:APDN) showed a performance of -11.67% in past 30-days.
Wall Street analysts have assigned a consensus price target of 1.5 to the stock, which implies a rise of 89.33% to its recent value today. Analysts have been projecting 1.5 as a low price target for the stock while placing it at a high target of 1.5. It follows that stock’s current price would drop -837.5% in reaching the projected high whereas dropping to the targeted low would mean a loss of -837.5% for stock’s current value.
Applied Dna Sciences Inc (APDN) estimates and forecasts
This year revenue growth is estimated to rise 51.67% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.3M for the same. And 1 analysts are in estimates of company making revenue of 2.02M in the next quarter. Company posted 929.63k and 797.52k of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 60.68% during past 5 years.
Applied Dna Sciences Inc (NASDAQ:APDN)’s Major holders
MATHER GROUP, LLC. is the top institutional holder at APDN for having 700.0 shares of worth $287.0. And as of 2024-06-30, it was holding 0.0803 of the company’s outstanding shares.
On the other hand, Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Nov 30, 2024, the former fund manager was holding 57.64 shares of worth $9188.0 or 0.10% of the total outstanding shares. The later fund manager was in possession of 26.01 shares on Dec 31, 2024, making its stake of worth around $4146.0 in the company or a holder of 0.05% of company’s stock.